[Treatment of cytomegalovirus infections in immunosuppressed patients].
Michon
C
C
Service de Pathologie Infectieuse, Hôpital Claude Bernard, Paris.
Girard
P M
PM
Ngovan
P
P
Simonpoli
A M
AM
Le Hoang
P
P
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000209:etiology; D017245:Foscarnet; D015774:Ganciclovir; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*
D000998:Antiviral Agents; D009943:Organophosphorus Compounds; D017245:Foscarnet; D010746:Phosphonoacetic Acid; D015774:Ganciclovir; D000212:Acyclovir
Traitement des infections à cytomégalovirus de l'immunodéprimé.